CX157 Completed Phase 1 Trials for Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01633437
Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers